• Preoperative assessment must take into account the effect that nephrectomy will have on the patient's postoperative renal function.
• Positioning the patient whether open or laparoscopic requires good communication and a robust approach to ensure that iatrogenic injuries are avoided.
• Nephron-sparing surgery ( partial nephrectomy) should be considered in patients with limited renal reserve.
• Adequate venous thromboprophylaxis is essential, particularly in those patients with a renal malignancy.
• Renal malignancy with extension into the renal vein and inferior vena cava will necessitate a different approach that requires careful forward planning with multiple specialities and should only be performed in specialist centres.
This paper will summarize the perioperative anaesthetic considerations for patients undergoing nephrectomy for both nonneoplastic and neoplastic disease of the kidney. It does not include the management of patients undergoing living donor nephrectomy.
Indications for nephrectomy
Nephrectomy for patients with renal cell carcinoma (RCC) was first described in 1969. 1 Surgical treatment varies with the pathology. Simple nephrectomy is the preferred option for those with non-neoplastic disease (e.g. trauma, non-functioning kidney with chronic infection) with radical nephrectomy being preferred in those with neoplastic disease. Radical nephrectomy implies resection of the whole of Gerota's fascia, including the perinephric fat, lymphatics, and the ipsilateral adrenal gland. The vast majority (∼90%) of solid renal masses are RCC; the remainder comprising mainly of transitional cell carcinoma or Wilm's tumour (in children). RCC accounts for between 1% and 3% of all visceral malignancies. It is twice as common in men when compared with women and most commonly presents in the seventh decade of life. The main environmental risk factor is cigarette smoking, contributing to one-third of all cases. Other important risk factors include obesity, hypertension, asbestos exposure, and acquired polycystic kidney disease. If symptomatic, presentation is usually with haematuria, loin pain, and a palpable mass. Non-specific symptoms such as malaise, weight loss, fever, and night sweats are relatively common. Small localized tumours are often asymptomatic and present with microscopic haematuria identified often through routine urinalysis.
Approximately 40% of RCCs are detected as an incidental finding on abdominal imaging. Tumour size is frequently small and confined to the kidney; however, ∼25% of cases present with distant metastases commonly in the lung, bone, liver, and brain. Metastases do not preclude surgery, nephrectomy still improving symptoms, quality of life, and prognosis. Five-year survival rates for RCC in the UK have improved over the last two decades with survival rates for grade I, II, III, and IV being 87%, 88%, 72%, and 46%, respectively. Tumour extension into the renal vein and/or inferior vena cava (IVC) is seen in up to 25% of cases and can present with severe pulmonary congestion and pulmonary embolism. Less than 10% will present with thrombus inside the IVC, with fewer than 2% with thrombus and tumour at the border of the right atrium. This group does gain a survival benefit from surgery despite the extensive involvement of the IVC and are discussed later in the paper.
Surgical approach
The surgical approach is individualized and largely determined by surgeon preference and by the disease stage (Table 1) , location of the pathology, the presence of multiple or bilateral pathology, baseline renal function, differential renal function, and history of a hereditary kidney cancer syndrome.
Radical nephrectomy is considered for cancer patients with stage I, II, and III disease. However, those patients with metastatic disease, at risk of developing severe renal impairment, and those with bilateral tumours are likely to be considered for nephron-sparing surgery.
The incision varies depending on the kidney location, tumour characteristics, body habitus, and surgeon's preference. The most commonly used incisions are flank, thoraco-abdominal, and trans-abdominal (chevron or anterior subcostal). Most kidneys can be removed safely via a transperitoneal subcostal approach. Radical nephrectomy can be undertaken using a laparoscopic technique in tumours which measure no more than 10 cm in diameter. Results appear to demonstrate similar survival, recurrence, and renal impairment rates regardless of technique or surgical approach.
Partial nephrectomy is performed in those patients with tumours smaller than 7 cm in diameter, those at risk of future significant renal impairment, tumours in a peripheral position (e.g. at one pole), those with bilateral tumours, and those with a solitary kidney. In selected patient groups, they have similar oncological outcomes. They can be performed using advanced laparoscopic techniques which require a great deal of technical skill. This may result in increased warm ischaemic times and as such, open partial nephrectomy may be preferable in certain circumstances (e.g. solitary kidney). Conversion from partial to radical nephrectomy is likely if a synchronous tumour or extension into the renal vein is discovered during surgery.
Laparoscopic nephrectomy has proven benefits of reduced analgesic requirements and reduced length of stay. 2 Further developments have emerged in laparoscopy, including hand-assisted procedures and robotic technology. In all such operations, particular attention needs to be paid to the cardiovascular and respiratory systems, given the need for pneumoperitoneum and the use of steep Trendelenburg. A laparoscopic approach may not be appropriate for those with severe ischaemic or valvular heart disease, given the haemodynamic instability or in patients with increased intracranial pressure. However, an attempt at laparoscopy combined with a low threshold for conversion to open surgery may be a reasoned approach. Preoperative assessment
In addition to providing a rigorous preoperative assessment, the anaesthetist needs to be cognizant of the impact surgery will have on the renal function in the immediate postoperative period. Cancer-specific survival for patients with certain grade and stage of renal cortical tumours is extremely good (e.g. 5 yr survival of males with stage 1 renal cancer is ∼84%, when compared with 5% with stage 4 disease) and hence consideration will be given to nephron-sparing surgery ( partial nephrectomy), particularly in patients with chronic kidney disease. After a radical nephrectomy, one-third of patients will be left with significantly reduced renal reserve, that is, a glomerular filtration rate (GFR) of <45 ml min −1 (∼CKD Stage 3B). This may impact upon subsequent management and prognosis during any future healthcare treatment. Serum creatinine, a calculation of estimated GFR (eGFR) in conjunction with an assessment of differential renal function using computerized isotope renography, is advocated. The results of which will influence the final choice of surgical approach and perioperative management. Preoperative assessment should attempt to assess functional capacity and assess for cardiorespiratory disease severity and should always take into account the degree of urgency for intervention. Patients are usually in their seventh decade of life and as such, the anaesthetist should make an attempt to exclude significant occult cardiorespiratory disease in those without prior history. Chemotherapy is not routine preoperative therapy as tumours are generally unresponsive to chemotherapy agents. Hence, unlike many other patients presenting for major surgery with malignant disease, an assessment of the impact of preoperative chemotherapy is generally not required.
Further investigations such as non-invasive cardiac stress tests, resting transthoracic echocardiogram, and static pulmonary function tests may be appropriate after initial clinical examination and history. This is particularly the case in the older, frailer patient to assist in appropriate perioperative medical optimization.
Cavo-atrial disease
Extension of disease into the IVC is apparent in 4-10% of all RCCs and has major anaesthetic and surgical implications. It is described in four stages (Table 2) by Novick and is helpful in determining the surgical conduct and approach. 4 Patients with cavo-atrial involvement may present with significant morbidity relating to the thrombus and will need I  T1  N0  M0  Stage II  T2  N0  M0  Stage III  T1 or T2  N1  M0  T3  N0 or N1  M0  Stage IV  T4 Any N Any M Any T M1
Anaesthesia for nephrectomy anticoagulation with heparin therapy before, during, and after the surgery. The thrombus needs detailed imaging to determine the stage and degree of IVC involvement typically using CT or magnetic resonant imaging. It is vital the imaging is up to date at the point of surgery as thrombus extension towards the heart in the interim before surgery will significantly change the management. The use of transoesophageal echocardiography (TOE) is extremely valuable in these scenarios and can provide more detailed information than CT or MRI when imaging retrohepatic tumour thrombus.
A typical case will require angio-emboliation of the kidney to be removed and insertion of a saline-filled balloon into the IVC ( proximal to the tumour) to prevent embolization of tumour and thrombus into the heart. After a chevron or roof-top incision and dissection onto the renal bed, the vascular surgeon will usually perform the cavotomy. This can only be performed once control is possible from below and above the tumour. A hepatobiliary surgeon will assist with dissection and removal of tumour from the intra and retro-hepatic regions of the IVC.
In most cases, preoperative arterial embolization of the kidney will facilitate surgery by allowing early ligation of the renal vein and its collaterals, thereby reducing excessive blood loss. This is associated with an angio-infarction syndrome of pain, nausea, hypertension, and fever. Ideally, the angio-embolization should be performed after induction of anaesthesia. At the author's institution, angio-embolization of the kidney occurs in a purpose-built hybrid theatre and after induction of anaesthesia for the comfort of the patient. In the past, many patients had IVC filters inserted. This is still done for palliative patients who are not due to have the tumour removed surgically but is no longer routine. If they are thought necessary, they should be fitted within 48 h of the operation so to avoid thrombi infiltrating the filter.
A multi-speciality approach consisting of radiology, anaesthesia, urology, vascular, and hepato-billiary specialists is essential. Cardiothoracic input will be required for those in which tumour thrombus extending up to the level of the diaphragm. For level 4 and occasionally level 3 tumour extent, the patient will need to go onto cardiopulmonary bypass to allow safe removal of the tumour. The decision to use CPBP in level 3 disease is made by balancing the advantages of better surgical access, control of bleeding, and reducing the impact on venous return against the risks associated with CPBP (i.e. in particular renal impairment, stroke, and air emboli). Deep hypothermic circulatory arrest is occasionally used in level 4 disease and those with more technically difficult surgery where the tumour is adherent to the cava wall. Supra-hepatic tumours that do not extend to the mouth of the right atrium may on occasion be approached via a small sternotomy with control of the IVC being achieved via a small incision in the pericardium.
Transfusion requirements can be huge and as such planning for major haemorrhage management including communication with the blood transfusion service is essential. Monitoring of coagulation parameters with modalities such as thromboelastography, blood gas analysis, and activated clotting time are all an essential part of management.
General intraoperative management
The appropriate vascular access is in part determined by the surgical approach. For a standard radical nephrectomy (open, laparoscopic, partial, or full) in a patient without significant co-morbidities, we would advocate a minimum of one wide gauge peripheral i.v. cannula. If the patient is to be positioned in the lateral position, it is ideal to place i.v. access in the ipsilateral limb to the kidney being removed. The authors have a very low threshold for insertion of invasive arterial cannula, allowing earlier detection and treatment of fluctuation in the patient's haemodynamic status. Many clinicians advocate additional non-invasive monitoring of the cardiac output in any major surgery and nephrectomy is no exception. Assistance in optimizing intravascular fluid therapy through stroke volume optimization is becoming more common practice. TOE is essential in those with stage 3 or 4 cavo-atrial disease. TOE is of particular importance in visualizing the most distal extension of the tumour/ thrombus within the cava. The imaging is of excellent quality and is essential in confirming that complete resection of the thrombus has been achieved.
Prevention of hypothermia through active warming should be initiated early with a forced-air warmer, heated mattress, and warmed i.v. fluids. A rigorous approach to venous thormboprophylaxis is very important, with the use of graduated stocking, low molecular weight heparin therapy, and pneumatic calf compression devices being considered mandatory. Bladder catheterization is routine, but the routine administration of prophylactic antibiotics is not. Antibiotics are only administered in certain higher risk patients such as those with significant renal dysfunction or infection within the renal tract. In these cases, a broad-spectrum antibiotic is usually administered such as co-amoxiclav with or without an aminoglycoside such as gentamicin (3-5 mg kg ) before knife to skin.
Cell salvage is generally advocated in uro-oncological surgery, despite early concerns of it theoretically being associated with an increased risk of tumour recurrence. These concerns have not been supported by the current literature and it appears a safe practice to adopt. In 2008, NICE published guidance on the issue but recommend the use of a leucocyte depleting filter as routine. Blood loss during nephrectomy is seldom over a litre, although many patients may present with an anaemia. As such, cell salvage is not usually a routine consideration. However, in those with caval involvement, it is not clear whether the use of cell salvage is associated with tumour recurrence or not. In view of the potential for massive blood loss, the authors recommend the use of cell salvage under these circumstances only.
Positioning needs consideration as both open and laparoscopic nephrectomy are commonly performed in the lateral position with varying degrees of tilt and flexion at the waist. This type of positioning is associated with an increased risk of pressure sores, nerve damage, venous pooling, corneal abrasion, and venous congestion. Both laparoscopic and the more extensive procedures (e.g. cava thrombectomy) may involve changing position intraoperatively. Care should be taken to assess new pressure points are adequately protected and to ensure that the tracheal tube and indwelling vascular access and monitoring is protected.
Lateral positioning and/or a degree of the Trendelenburg will generally further reduce FRC, increase ventilation-perfusion mismatch, and is associated with the development of atelectasis. Thrombus involves the right atrium Anaesthesia for nephrectomy
In the laparoscopic approach, a pneumoperitoneum may further aggravate respiratory function but may also have a deleterious effect on the venous return and cardiac output, particularly if intra-abdominal pressures increase above 20 mm Hg. Hence, laparoscopic surgery may not be well tolerated in patients with significant systolic dysfunction or those with co-existing coronary artery disease with ventricular hypertrophy. A combination of general and a loco-regional technique usually combine well. Low thoracic epidural analgesia, paravertebral block, or the use of wound catheters and local infiltration all have roles in the approach to analgesia. Open nephrectomy is associated with a significant degree of acute pain and will require opioid analgesia if regional analgesia is avoided or not successful. Transversus abdominis plane block and paravertebral blocks are known to reduce opioid requirements without the hypotension associated with epidurals, but their role in nephrectomy is less well established. The dermatomes that require coverage with regional anaesthesia are dependent on which incision is used (Table 3) . Increasingly, wound infusion catheters are being effectively used to complement opioid patient-controlled analgesia (PCA). Regional anaesthesia is usually avoided in those with cavo-atrial involvement due to the ongoing anticoagulation and also the extensive blood loss may cause them to become coagulopathic.
Although laparoscopic nephrectomy has proven reduced analgesic requirements, patients will still require regular strong opioids either in the form of an infusion or a PCA pump and also regular simple analgesics such as paracetamol. The use of drugs which rely on renal metabolism and excretion should be used cautiously in those with preoperative evidence of poor renal reserve and complete avoidance of non-steroidal antiinflammatory diseases is recommended.
For level 3 cava disease operated on without CPBP, there is likely to be the use of both the Pringle manoeuvre and crossclamping of the vena cava. This will cause a decrease in venous return and subsequent cardiac output. Such haemodynamic instability can be very poorly tolerated, but the haemodynamic response is poorly predicted. The effect will largely depend upon whether the patient has complete occlusion of the IVC at presentation for surgery and the extent to which a collateral circulation has developed. One option is to see how well crossclamping is tolerated before proceeding with surgery on the vena cava. If problems arise, veno-venous bypass or full cardiopulmonary bypass may need to be considered.
Operative-specific complications have decreased significantly with advancement in surgical practice; however, they are still significant and listed in Table 4 . Mortality after radical nephrectomy is considered to be <0.5% and is usually due to complications such as pulmonary embolism and myocardial infarction.
Postoperative
Postoperative care can be delivered with level 1 surgical ward care for a standard radical nephrectomy (open or laparoscopic). There should be a low threshold for arranging a higher level of care for individuals with significant co-morbidities and those planned to have continuous thoracic epidural analgesia in the immediate postoperative period. Those with cavo-atrial disease should all be cared for after operation in a critical care environment, although the exact level of care will be dictated by the magnitude of surgical trauma and whether veno-venous or cardiopulmonary bypass has been required.
Conclusion
Perioperative management varies significantly and there is a wide spectrum of disease and patient groups who may present for nephrectomy. The anaesthetist must be cognizant of the various surgical approaches and be prepared to assist surgical colleagues and patients in agreeing the best approach to their disease based on the findings at preoperative assessment and staging of malignant disease. These findings influence preoperative optimization, referral to allied specialities, determine the optimal timing of surgery, and allow the team to provide an individualized approach. Comprehensive imaging, MDT discussion, and preoperative planning are frequently necessary between several specialities and as such nephrectomy in the 21st century still remains a potentially challenging case for the anaesthetist.
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